Feline herpesvirus 1 (FHV) is an important cause of feline ocular and respiratory disease, but the role the virus plays in central nervous system disease of cats has not been explored. The study described here was performed to validate an indirect enzyme-linked immunosorbent assay (ELISA) to detect FHV-specific IgG antibodies for use in feline epidemiologic, ocular, and central nervous system disease studies. The indirect IgG ELISA was applied to serum, aqueous humor, and cerebrospinal fluid from cats. Serum FHV IgG ELISA results were compared with those of serum neutralization in client-owned cats and laboratory-housed cats following vaccination. Of the 100 client-owned cats tested by ELISA, 97 had detectable FHV IgG; 95 had titers Ͼ32. The FHV IgG ELISA was more sensitive than serum neutralization and could be used with aqueous humor and cerebrospinal fluid. Cats with inflammatory central nervous system or ocular diseases had significant leakage of serum proteins into aqueous humor and cerebrospinal fluid, necessitating use of cutoff values derived from serum when these fluids were assessed.
Feline herpesvirus 1 (FHV) is one of the most common infectious causes of feline respiratory disease and feline ocular disease. It has been suggested that at least 50% of respiratory disease in cats results from FHV infection. 9 The classic clinical feature of infection is rhinitis with resultant sneezing and nasal exudate that can range from serous to purulent or bloody. Conjunctivitis, keratitis, and corneal sequestra are ocular syndromes that develop in some infected cats. 8 The virus can enter latency in neural tissues, with exacerbation of disease occurring at times of stress. Recurrent disease is generally milder and of shorter duration than primary disease. Herpesviruses have been associated with intraocular inflammation 3,11 and central nervous system (CNS) disease 4, 12 in humans; the role FHV infection plays in these syndromes in cats is under investigation.
Antibodies against FHV in feline serum are often detected using serum neutralization (SN). 10 Because FHV can have prolonged latent periods, the presence of antibody in serum suggests prior infection but does not necessarily correlate with clinical disease. Positive SN titers do not always correlate with presence of FHV as determined by fluorescent antibody (FA) or virus isolation (VI) from a suspected site of infection; FHV has been documented in ocular tissues of many From cats negative for antibody by SN. 7 A more sensitive FHV antibody test is needed for epidemiologic studies. Enzyme-linked immunosorbent assays (ELISAs) are often more sensitive than SN for the detection of antibodies. Results of ELISAs can be quantified by measuring absorbance values with a spectrophotometer. Herpesvirus-specific antibodies have been detected by ELISA in human serum, aqueous humor, and cerebrospinal fluid (CSF). 1, 3, 12 Results of ELISAs can be readily applied to local antibody production indices using aqueous humor or CSF. 5 Documentation of herpesvirus antibody production in the eyes or CNS has been used as evidence of ocular and CNS disease due to herpesviruses in people. 3, 4, 11, 12 The purpose of the study described here was to validate an ELISA to detect IgG antibodies against FHV for use in feline epidemiologic, ocular, and CNS disease studies.
Materials and methods
Antigen preparation. FHV was propagated in Crandell feline kidney cells (CrFK). FHV nucleocapsid purification was achieved using previously developed sucrose gradient centrifugation methods. 2 Virus fractions (1.20-1.22 g/cm 3 ) were pooled and dialyzed against TNE buffer (0.01 M Tris, 0.15 M sodium chloride, 0.001 M EDTA, pH 7.2). Fractions were maintained at Ϫ20 C until needed.
FHV IgG ELISA. Appropriate wells of a microtitration plate a were sensitized with 50 l of FHV antigen diluted 1: 30 in 0.01 M phosphate-buffered saline solution (PBSS; pH 7.2). After a 24-hr incubation at 4 C, the sensitized plate was washed 3 times with 200 l/well 0.01 M PBSS (pH 7.2) containing 0.05% Tween 20 (PBSS-TW). For serum, samples were diluted 1:16 in PBSS-TW, and 100 l was added to the first well of the sample row. Eight, 2-fold serial di-lutions (50 l/well) in PBSS-TW were made to a final dilution of 1:2,048. Samples with titers Ͼ1:2,048 were titrated to end point in a subsequent assay. Positive and negative serum controls were diluted 1:64 in PBSS-TW, and 50 l was pipetted to triplicate wells. For aqueous humor and CSF samples, samples and controls were diluted 1:16 in PBSS-TW, and 50 l was pipetted into triplicate wells. The plates were incubated for 30 min at 37 C and washed as before in PBSS-TW. Anti-feline IgG b was diluted 1:2,000 in PBSS-TW, and 50 l was added to appropriate wells. Following a 30-min incubation at 37 C, the plates were washed as described. A 1:1,000 dilution of o-phenylenediamine solution in 0.05 M sodium acetate buffer (pH 4.5) plus 0.001% hydrogen peroxide was added to all wells (50 l/well). After incubation for 30 min at 20 C in the dark, 25 l of 8 N sulfuric acid was added to each well to stop the color reaction. Absorbance of each dilution was measured by an automated micro-ELISA reader c equipped with a 492-nm filter. Enzyme and substrate control wells were assessed on each plate.
Serum samples from 12 specific-pathogen-free (SPF) cats were diluted 1:16 in PBSS-TW and assayed in quadruplicate wells. The mean absorbance of these samples was divided by the mean absorbance of the negative control, giving a correction factor of 2.1. On all subsequent plates, the mean absorbance of the negative control wells was multiplied by this correction factor to give the positive cutoff value. The sample titer was considered to be the last serum dilution with an absorbance value greater than the positive cutoff value.
Preliminary experiments determined optimal conditions for detection of FHV IgG antibodies. Multiple microtitration plates, antigen concentrations, serum dilutions, and incubation times were assessed. To assess interassay variation, the ratio of the mean absorbance of the positive control wells to the mean absorbance of the negative control wells was calculated for 5 ELISA plates run consecutively over 10 days, and the coefficient of variation also was calculated. To assess intraassay variation, 2 positive serum samples and 3 negative serum samples were assayed twice on the same plate.
Serum neutralization. The SN test was performed as previously described 10 with the following adaptations. Serum was separated from clotted whole blood by centrifugation at 1,500 ϫ g for 10 min and then heat inactivated at 56 C for 30 min. To sterile 96-well culture plates, a 25 l of HEPES buffered minimum essential medium was added to all but row A wells. Virus-specific control antiserum or the sample serum was added (50 l) to row A wells in triplicate. Sera were diluted down the rows, resulting in all wells containing 25-l total volumes in a titer range of 1:2-1:256. FHV was diluted to give 100 TCID 50 (tissue culture infectious dose, 50%) and was added to 2 of 3 sample wells (25 l/well). Plates were incubated for 1 hr at 37 C in 5% CO 2 . Following the 1-hr sample plate incubations, 150 l of CrFK cell suspension was added to all wells. Plates were read for cytopathic effects (CPE) following a 72-hr incubation at 37 C in 5% CO 2 . Test sera were examined for CPE, with the highest dilution of serum capable of completely neutralizing the virus (no CPE) indicating the titer. SN titers of Ͻ1:2 were defined as negative.
Serum studies. Age-matched adult cats (n ϭ 4) were pur-chased and housed individually. Litter was changed daily, commercial dry cat food was fed ad libitum, fresh water was available continuously, and routine sanitation and insect control were maintained. The cats had not been vaccinated previously. Serum was separated from clotted whole blood that had been collected by jugular venipuncture prior to vaccination and weekly for 6 wk after vaccination. A commercially available combination of modified-live FHV, feline calicivirus, feline panleukopenia, and Chlamydia psittaci vaccine d was administered in 1-ml volumes subcutaneously to each cat in week 0 and week 3. Sera collected in October (n ϭ 50) or April (n ϭ 50) from client-owned cats were selected randomly from the serum bank at the Diagnostic Laboratory at Colorado State University for assay in the FHV IgG ELISA. Of these samples, some had been evaluated for presence of FHV in ocular tissues by FA (n ϭ 8) or VI (n ϭ 2). 7 All sera were frozen at Ϫ20 C or Ϫ70 C until assayed. SN results were available for 40 serum samples from client-owned cats.
Aqueous humor and CSF studies. In preliminary experiments, aqueous humor and CSF from FHV-seronegative (ELISA negative, SN negative) cats had absorbance values of 0-0.01 in the FHV IgG ELISA. The FHV-negative serum control had an absorbance value of approximately 0.2 in the FHV IgG ELISA. During uveitis and CNS inflammatory diseases, serum protein leaks into the aqueous humor and CSF, respectively. To determine the effect of leakage of serum proteins into the aqueous humor or CSF on background absorbance in the FHV IgG ELISA, the following 2 experiments were performed. In the first experiment, ELISA-positive sera (2,048), SN-positive sera (64), and ELISA-negative, SN-negative sera were added to individual aqueous humor and CSF samples from FHV-naive cats to give 0%, 20%, 40%, 60%, 80%, and 100% serum/aqueous humor or serum/CSF ratios. The aqueous humor and CSF samples were then diluted 1:10 in PBSS-TW and assayed in the FHV IgG ELISA. Mean absorbance values were calculated for each sample. In the second experiment, serum and aqueous humor from client-owned cats with uveitis (n ϭ 4) and serum and CSF from client-owned cats with inflammatory CNS disease (n ϭ 4) were diluted 1:100 in PBSS-TW and assayed in a quantitative total IgG ELISA. 5 The ratio of total IgG in aqueous humor/serum or CSF/serum was calculated for each cat.
Specificity studies. Specificity of the FHV IgG ELISA was assessed in 2 experiments. In the first experiment, previously described immunoprecipitation techniques were modified for FHV investigation. 2 ELISA-positive, SN-positive (n ϭ 3) and ELISA-negative, SN-negative (n ϭ 3) samples were assayed to determine whether viral proteins were recognized. In the second experiment, ELISA-positive, SNnegative sera (n ϭ 5) were mixed 1:1 with FHV in an attempt to absorb antibodies reactive in the ELISA. After incubating overnight at 4 C, the sera were centrifuged at 10,000 ϫ g for 10 min. An aliquot of each serum sample prior to incubation with FHV was diluted 1:32 in PBSS-TW, and each corresponding absorbed serum sample was diluted 1:16 (giving a total dilution of 1:32) in PBSS-TW and assayed in triplicate wells in the FHV ELISA. 
Results
Reproducibility of the FHV IgG ELISA was estimated by interassay and intraassay variation. Interassay variation was estimated to be 11.2% based on the coefficient of variation of the ratio of positive to negative control absorbances for 5 assays performed over 10 days. Positive titers did not vary more than 2-fold in the intraassay variation study; negative samples were negative for both replicates.
In the immunoprecipitation specificity experiment, ELISA-positive, SN-positive serum samples consistently produced 2 bands of 135-155 kD and variably produced 3 smaller bands of 31, 38, and 63 kD (Fig.  1 ). The larger bands may represent the gB glycoprotein of FHV. 6 ELISA-negative, SN-negative samples were negative for bands. Changes in absorbance values for the 5 ELISA-positive, SN-negative serum samples after incubation with FHV were 45.2%, 24.6%, 37.6%, 14.2%, and 10.4%.
Absorbance values of healthy SPF cat aqueous humor and CSF were Ͻ0.015 in the FHV IgG ELISA (Fig. 2) . When FHV-positive serum or FHV-negative serum was added to aqueous humor or CSF, absorbance values dramatically increased when as little as 20% serum was added (Fig. 2) . The ratios of aqueous humor to serum absorbance values in the total IgG ELISA from 4 client-owned cats with uveitis were 0.94, 0.83, 0.82, and 0.34. The ratios of CSF to serum absorbance values in the total IgG ELISA from 4 client-owned cats with inflammatory CNS disease were 0.83, 0.63, 0.25, and 0.25. These results show that serum readily leaks into the aqueous humor and CSF during inflammatory conditions. Alternatively, the eyes or CNS could produce increased concentrations of IgG during inflammatory conditions.
Of the 4 vaccinated cats, 2 had FHV IgG ELISA titers of 1:256 prior to vaccination at week 0. FHV IgG ELISA titers for these 2 cats peaked at 1:16,384 at week 4. The 2 cats that were FHV seronegative prior to vaccination had ELISA-detectable concentrations of FHV IgG on week 4; both cats maintained titers of 1: 32 at weeks 4, 5, and 6. SN did not detect herpesvirus antibodies in any serum sample from these 4 cats.
In the FHV ELISA, naturally exposed or vaccinated client-owned cats showed an overall seroprevalence of 97%; titers ranged from negative to 1:8,192 (Table 1) . Geometric mean titers for samples collected in October or April were 484.4 and 352.1, respectively. For the 40 sera from which SN and ELISA results were both available ( Table 2) , all had FHV IgG by ELISA and 28 were positive by SN (sensitivity of SN ϭ 70%). Sera positive for FHV antibody by both methods differed greatly in end point titer ( Table 2) .
Of the 5 naturally exposed or vaccinated clientowned cats positive for FHV antigen by FA, 4 were positive for FHV antibody in serum by SN and 5 were positive for FHV IgG in serum by ELISA. Of the 3 cats negative for FHV antigen by FA, 1 was positive for FHV antibody in serum by SN and 3 were positive for FHV IgG in serum by ELISA. Of the 2 clientowned cats positive for FHV by VI, SN did not detect 
Discussion
Our interassay and intraassay variation studies show that the FHV IgG ELISA results are reproducible. Detection of FHV antibodies by ELISA but not SN in cats with proven FHV infection or known vaccination suggests that this ELISA is more sensitive than SN. The ability to absorb antibody activity from ELISApositive, SN-negative serum samples supports this conclusion. Detection of FHV antibodies in a greater percentage of client-owned cats by ELISA than by SN and the finding that serum samples positive for FHV antibodies by ELISA and SN generally have greater titers by ELISA also support the greater sensitivity of the ELISA. Although the FHV SN detects only neutralizing antibodies, the FHV IgG ELISA potentially detects antibodies against multiple FHV antigens, which is a likely explanation for the sensitivity differences between the assays. ELISA-positive, SN-positive and ELISA-negative, SN-negative results were apparently accurate based on radioimmunoprecipitation. Bands detected were consistent with serum antibodies to FHV viral glycoproteins. 6 Prevalence studies based on FHV SN test results have likely underestimated the number of cats exposed to FHV. In our small study of 40 cats, the prevalence of FHV exposure via natural infection or modified live vaccination was estimated at 70% or 100% by SN or ELISA, respectively. In our vaccination study, FHVseronegative cats developed peak FHV IgG ELISA titers of 1:32 4 weeks after vaccination; FHV-seropositive cats developed an 8-fold increase in IgG ELISA titer within 1 week after initial vaccination and devel-oped peak antibody titers of 1:16,384. Because the FHV-seropositive cats were laboratory reared and not previously vaccinated, previous FHV infection had likely occurred. The dramatic increase in antibody titer in these 2 cats compared with the 2 seronegative cats probably reflects an anamnestic response to previous infection.
Of the 100 client-owned cats tested by ELISA, 97 had detectable FHV IgG, and 95 had titers Ͼ32. Although most client-owned cats were probably vaccinated, the titer magnitudes appear to be greater than can be explained by vaccine exposure alone. These results suggest the cats were also naturally exposed to FHV, supporting the hypothesis that FHV is ubiquitous in nature and that subclinical infection in cats is common.
Because clinical information was not available for the majority of animals assessed in this study, the positive and negative predictive values of ELISA and SN could not be determined. However, of the 7 cats with clinical signs of FHV infection and documentation of organism by VI or FA, 3 were negative for serum antibodies by SN, suggesting that the negative predictive value of this test is poor. Further studies are needed to evaluate the use of FHV antibody assays in prediction of FHV infection and disease.
The FHV IgG ELISA can be used to detect FHV IgG in aqueous humor and CSF. Aqueous humor and CSF from normal animals have minimal background absorbance in the FHV IgG ELISA, but when as little as 20% serum is added to aqueous humor or CSF, the absorbance values approximate those of serum. Our total IgG results from cats with inflammatory ocular or CNS diseases suggest that serum readily leaks into the aqueous humor and CSF or that protein production by ocular or CNS tissues actively occurs. The ratios of total IgG in these samples to that in serum were variable but could approach 1.0. Thus, when ELISA is used to measure FHV antibodies in aqueous humor or CSF from cats with inflammatory diseases, absorbance values used for determination of significant cutoff values for serum should be used.
